Shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Get Rating) traded down 4.7% during mid-day trading on Tuesday . The company traded as low as $6.27 and last traded at $6.28. 585,829 shares traded hands during trading, a decline of 84% from the average session volume of 3,674,282 shares. The stock had previously closed at $6.59. […]
Should You Buy or Sell Fate Therapeutics Stock? Get The Latest FATE Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Fate Therapeutics, Inc. (NASDAQ:FATE – Get Rating) was up 6.2% during mid-day trading on Monday . The company traded as high as $6.43 and last traded at $6.38. Approximately 168,893 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 3,680,949 shares. The stock had previously closed at $6.01. […]
StockNews.com upgraded shares of Fate Therapeutics (NASDAQ:FATE – Get Rating) from a sell rating to a hold rating in a research note released on Wednesday morning. Several other research firms have also weighed in on FATE. Truist Financial reaffirmed a hold rating and set a $7.00 price objective (down previously from $46.00) on shares of […]
StockNews.com upgraded shares of Fate Therapeutics (NASDAQ:FATE – Get Rating) from a sell rating to a hold rating in a research note released on Wednesday morning. Other research analysts have also recently issued reports about the stock. Truist Financial reiterated a hold rating and set a $7.00 price objective (down from $46.00) on shares of […]